Semaglutide Weight Loss Drug Examined

Semaglutide weight loss drug is the new talk of the fat loss industry. After clinical trials which lasted 1.5 years concluded it was approved by the FDA in June of 2021.

It must be noted that Semaglutide is also called Wegovy. Does it really work? Is it safe? Should you consider it as an option in your weight loss program? Watch the video above now to get all these important questions answered.

In the Semaglutide weight loss drug clinical trial 1,961 individuals were followed for 1.5 years. They were split up into two groups - Semaglutide 2.4 mg shot group and the placebo. It is important to note that both groups were encouraged to add weight loss program protocols in place which included decreasing caloric intake by 500 calories each day in addition to 150 minutes of exercise weekly. Therefore, it wasn't just a "quick fix" shot. It was medication powered with lifestyle changes. The following results were reported:

Semaglutide Weight Loss Drug Clinical Trials

Semaglutide weight loss drug

• Semaglutide weight loss drug (1x/week) resulted in a loss of 14.9% of body weight or 33 lbs.
• Placebo group showed a weight loss of 2.4% or 5.7%.

Inside the video above, I explain who this particular medication is for. Since it is a prescription medication there are clear parameters for those who can receive it. Watch the video above now for more information.

Originally Semaglutide was created for type 2 diabetics. One of the side effect for this population was weight loss and greater satiety. Therefore, a medication for weight loss came to mind.

Watch the Semaglutide weight loss drug video above for even more important information. Also, fill in the box below for your 100% FREE access to Fat Loss Forever - The Top 7 Ways To Prime Your Brain For Permanent Fat Loss.